|Articles|February 18, 2016
INC Research Kicks Off Sites Initiative
The goal of the Catalyst program is to strengthen collaborations with clinical research sites worldwide through network and community approaches.
Advertisement
INC Research officially launched the company's Catalyst program, designed to strengthen collaborations with clinical research sites worldwide. Investigative sites that take part in the program will have the opportunity to participate in an increased volume of clinical studies, according to INC. Participation is by invitation only and the initial focus is on oncology and vaccine sites in the U.S. and the Asia-Pacific region.
The program includes two components-the Catalyst Site Network and the Catalyst Community.
Read the full release .
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Articles
- How Sponsors Can Modernize Tools to Support Physicians
September 9th 2025
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
ACT Brief Episode 7: Veeva and Merck Trial Efficiency, DCT Barriers, and Glucose Monitoring Strategies
2
Pfizer, BioNTech’s Comirnaty Shows Strong Immune Response in Phase III Trial for COVID-19
3
Beyond the Algorithm: How Human-Centered AI Design Can Drive Clinical Trial Success
4
Summit Therapeutics’ Bispecific Antibody Shows Positive Survival Trend in Non-Small Cell Lung Cancer
5